AAM
MNTA

Alpine Associates Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Alpine Associates Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,436,000
Closed -$75.4M – 62
2020
Q3 		$75.4M Buy
+1,436,000
New +$59.4M 3.96% 11

Alpine Associates Management's MNTA Position: Q4 2020 in Review

Alpine Associates Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,436,000 shares — an estimated $75.4M sold.

Alpine Associates Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $75.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Alpine Associates Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Alpine Associates Management sold 1,436,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $75.4M.
  • Alpine Associates Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Alpine Associates Management's Momenta Pharmaceuticals, Inc. position peaked at $75.4M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Alpine Associates Management's 13F filing for Q4 2020, filed 10 Feb 2021.